News and Breakthroughs
Find the latest news and discoveries, as well highlights from Lurie Cancer Center’s programs and events through the links below. To learn more about our accomplishments and the people who make them possible, visit the article archive for older news and read our 2020 Year in Review.
Visit our gallery to view a wide range of photos and videos for oncology professionals, cancer patients and families, cancer survivors, caregivers and community members.
Important Questions Answered by Our Scientists. On January 12, Lurie Cancer center held a virtual Town Hall meeting on COVID-19 for cancer patients.
A Northwestern Medicine study has found that a new combination immune therapy treatment not only extended cancer patients’ lives better than other treatments, it also was less toxic to their overall health than other drugs on the market.
The Lurie Cancer Center is pleased to announce the recipients of a new $150,000 award from the H Foundation that could impact outcomes and improve the standard of care for patients with glioblastoma. The funding will provide the beginning infrastructure needed for an interdisciplinary team of investigators led by Derek Wainwright, PhD, and Theresa Walunas, PhD.
Jane Winter, MD, a highly regarded lymphoma expert, will serve as president of the American Society of Hematology for a year-long term through December 2022.
Northwestern Medicine investigators have discovered a novel mechanism linking an intercellular adhesion molecule with genetic inflammatory skin diseases.
Jane N. Winter, MD, a highly regarded lymphoma expert, will serve as president of the American Society of Hematology (ASH) for a year-long term through December 2022.
Of the more than 20 episodes of the medical school's Breakthroughs podcast produced in 2021, the most popular ranged across specialties from gastroenterology to nanotechnology. Listen to the top five episodes of the year and earn Continuing Medical Education credit.
A new Northwestern Medicine study reports that DNA manifested as knot-like folds and third rungs between DNA’s two strands may drive cancer development and an important regulatory enzyme could be associated with the formation of these unusual structures.
A team of investigators have discovered a novel genomic variant that may help clinicians predict which patients will experience cardiotoxicity from a widely used chemotherapy drug, according to a Northwestern Medicine study.
A recent study showed that targeted radioembolization alongside chemotherapy improved progress-free survival for patients with metastatic colon cancer.
Mutations in a histone regulator protein are connected to both a rare neurodevelopmental disorder and to some cancers, according to a recent study.
Amy Heimberger, MD, has been named interim associate director of Translational Research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, where she will oversee the development and coordination of translational science efforts within the Lurie Cancer Center, effective January 1. 2022.
Lurie Cancer Center is pleased to announce three new senior leadership appointments.
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and malignant of primary brain tumors — might benefit from immunotherapy.
Project will accelerate the development of precision diagnostics and therapeutics
For people who have had a cancer diagnosis, undergoing imaging scans can lead to a variety of emotions. It is common to feel stress or worry in the period before a medical test, during the test, and while waiting for test results. We call these feelings “scanxiety.”
Scientists have discovered a potential biomarker that could more accurately identify which patients with non-hypermutated cancers will respond to specialized immunotherapy drugs.
A previously unknown mechanism involving the protein Scribble helps maintain polarity in cells, according to a Northwestern Medicine study.
Fatty acid uptake produces an epigenetic modification that is required for cancer metastasis, according to a study published in Nature.
Our genetic code is millions of times more efficient at storing data than existing solutions, which are costly and use immense amounts of energy and space. In fact, we could get rid of hard drives and store all the digital data on the planet within a couple hundred pounds of DNA.
On October 28, 2021, Northwestern University leadership joined Ann Lurie and other longstanding donors and friends for a special dinner commemorating the 30th anniversary of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University naming and dedication.
Northwestern investigators have identified a novel approach to control the hierarchical assembly of protein pathways with DNA, according to a study published the Proceedings of the National Academy of Sciences (PNAS).
TG2, an enzyme known to help cancers spread more quickly, also plays a role in regulating T-cells — opening the door to dual inhibition, according to a recent Northwestern Medicine study.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a Merit Extension Award from the National Cancer Institute, one of only two Comprehensive Cancer Centers in the nation to earn the recognition.
From teasing out determinants of health disparities to developing precision medicine treatments, clinicians and scientists from the Lurie Cancer Center are dramatically changing the landscape for all men with prostate cancer.
The underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma, which accounts for 80 percent of all kidney cancers, according to a recent study.
In this newly created role, Platanias will oversee all cancer-related activities at Northwestern, and will retain his current role as director of the Lurie Cancer Center.
A new generation of philanthropic leadership will support the mission and goals of the Lurie Cancer Center.
See more news in the article archive.